NASDAQ | ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index.
The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry.
Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 15.69% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 9.97% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 7.97% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 7.23% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 5.32% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 5.11% |
| ICLR | ICON PLC | Healthcare | Diagnostics & Research | 4.51% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.17% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 3.92% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 3.83% |
| BGNE | BeiGene Ltd | Healthcare | Biotechnology | 3.35% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.05% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.88% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 2.58% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 2.49% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.42% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 2.41% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 2.34% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 2.10% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 2.04% |